Bruno Pougault: Oral Anticoagulants Are Essential, But Not a ‘Fix-All’
Bruno Pougault, Global Marketing Hemostasis Product Manager at HORIBA, shared on LinkedIn about a recent article by Eva Soler-Espejo et al, published in JAHA:
”Oral anticoagulants: Essential, but not a ‘fix-all’.
A huge thank you to the authors of this recent study in JAHA (DOI: 10.1161/JAHA.125.046694) for highlighting the reality of residual risk.
Even with optimal treatment, the risk of stroke in AFib patients persists.
This research is a vital reminder that we must look beyond the prescription: managing comorbidities and lifestyle remains just as crucial as the medication itself.
Great work by the team for pushing the boundaries of comprehensive cardiovascular care!”
Title: Atherogenic Index of Plasma and Residual Risk in Anticoagulated Patients With Atrial Fibrillation: The Prospective Murcia Atrial Fibrillation Project III Cohort
Authors: Eva Soler-Espejo, Yang Chen, José M. Rivera-Caravaca, María P. Ramos-Bratos, Francisco Marín, Vanessa Roldán, Gregory Y. H. Lip
Read the Full Article on JAHA
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience